Atherosclerosis — a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall — is the underlying cause of heart attacks and strokes. Researchers have now demonstrated that a receptor for prostaglandin-E2 plays a key role in the development of atherosclerosis. The findings point to this receptor and its signaling pathways as molecular targets for modulating atherosclerosis development.